MBAIF (MedBright AI Investments) Sloan Ratio % : 40.63% (As of Aug. 2024)

View and export this data going back to 2017. Start your Free Trial

What is MedBright AI Investments Sloan Ratio %?

Richard Sloan from the University of Michigan was first to document what is referred to as the "accrual anomaly". His 1996 paper found that shares of companies with small or negative accruals vastly outperform (+10%) those of companies with large ones.

MedBright AI Investments's Sloan Ratio for the quarter that ended in Aug. 2024 was 40.63%.

Warning Sign:

When sloan ratio (-70.67)% higher than 25% or lower than -25%, earnings are more likely to be made up of accruals.

As of Aug. 2024, MedBright AI Investments has a Sloan Ratio of 40.63%, indicating earnings are more likely to be made up of accruals.

MedBright AI Investments Sloan Ratio % Historical Data

The historical data trend for MedBright AI Investments's Sloan Ratio % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MedBright AI Investments Sloan Ratio % Chart

MedBright AI Investments Annual Data

Trend

Feb15

Feb16

Feb17

Feb18

Feb19

Feb20

Feb21

Feb22

Feb23

Feb24

Sloan Ratio %

Get a 7-Day Free Trial

-1,565.33

-129.66

15.22

50.77

-70.68

MedBright AI Investments Quarterly Data
	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23	Feb24	May24	Aug24
Sloan Ratio %	Get a 7-Day Free Trial															-133.95	-99.21	-71.05	-63.27	40.63

Competitive Comparison of MedBright AI Investments's Sloan Ratio %

For the Asset Management subindustry, MedBright AI Investments's Sloan Ratio %, along with its competitors' market caps and Sloan Ratio % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

MedBright AI Investments's Sloan Ratio % Distribution in the Asset Management Industry

For the Asset Management industry and Financial Services sector, MedBright AI Investments's Sloan Ratio % distribution charts can be found below:

* The bar in red indicates where MedBright AI Investments's Sloan Ratio % falls into.

MedBright AI Investments Sloan Ratio % Calculation

Earnings contain a lot of non cash earnings which is called accruals. The Sloan ratio is a way to identify firms with low non-cash or accrual-derived earnings relative to their cash flow.

MedBright AI Investments's Sloan Ratio for the fiscal year that ended in Feb. 2024 is calculated as

Sloan Ratio	=	(Net Income (A: Feb. 2024 )	-	Cash Flow from Operations (A: Feb. 2024 )
	-	Cash Flow from Investing (A: Feb. 2024 ))	/	Total Assets (A: Feb. 2024 )
	=	(-5.302	-	-1.225
	-	-0.845)	/	4.573
	=	-70.68%

MedBright AI Investments's Sloan Ratio for the quarter that ended in Aug. 2024 is calculated as

Sloan Ratio	=	(Net Income (TTM)	-	Cash Flow from Operations (TTM))
	-	Cash Flow from Investing (TTM))	/	Total Assets (Q: Aug. 2024 )
	=	(-0.708	-	-1.128
	-	-1.256)	/	4.125
	=	40.63%

MedBright AI Investments's Net Income for the trailing twelve months (TTM) ended in Aug. 2024 was -0.39 (Nov. 2023 ) + 0.141 (Feb. 2024 ) + -0.237 (May. 2024 ) + -0.222 (Aug. 2024 ) = $-0.71 Mil.
MedBright AI Investments's Cash Flow from Operations for the trailing twelve months (TTM) ended in Aug. 2024 was -0.522 (Nov. 2023 ) + -0.327 (Feb. 2024 ) + -0.143 (May. 2024 ) + -0.136 (Aug. 2024 ) = $-1.13 Mil.
MedBright AI Investments's Cash Flow from Investing for the trailing twelve months (TTM) ended in Aug. 2024 was -0.598 (Nov. 2023 ) + -0.31 (Feb. 2024 ) + -0.269 (May. 2024 ) + -0.079 (Aug. 2024 ) = $-1.26 Mil.

MedBright AI Investments (OTCPK:MBAIF) Sloan Ratio % Explanation

A former University of Michigan researcher, Richard Sloan's 1996 paper found that shares of companies with small or negative accruals vastly outperform (+10%) those of companies with large ones. In fact, for the 40-year period between 1962 and 2001, buying the lowest accrual companies and shorting the highest accrual companies resulted in an average annual compounded return of 18%, more than double the S&P 500's 7.4% annual return over the same period.

According to How to Beat the Market with the Sloan Ratio:

If the Sloan Ratio is between -10% and 10%, the company is in the safe zone and there is no funny business with accruals.

If the Sloan Ratio is less than between -25% and -10% on the negative side, and between 10% and 25% on the positive side, this is a warning stage of accrual build up.

If the Sloan Ratio is less than -25% or greater than 25%, and this ratio is consistent over several quarters or even years, be careful. Earnings are highly likely to be made up of accruals.

As of Aug. 2024, MedBright AI Investments has a Sloan Ratio of 40.63%, indicating earnings are more likely to be made up of accruals.

MedBright AI Investments Sloan Ratio % Related Terms

Thank you for viewing the detailed overview of MedBright AI Investments's Sloan Ratio % provided by GuruFocus.com. Please click on the following links to see related term pages.